ALINA CUMMINS: Open Payments
NPI 1851753826 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,331 in 110 payments from 26 companies in 2025. Trend: 2023 $927 · 2024 $2,168 · 2025 $2,331
Food & beverage: $2,331
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $326 |
| Abbott Laboratories | 8 | $230 |
| Novo Nordisk Inc | 12 | $219 |
| SANOFI-AVENTIS U.S. LLC | 7 | $194 |
| Dexcom, Inc. | 18 | $184 |
| Globus Medical, Inc. | 4 | $149 |
| Radius Health, Inc. | 5 | $123 |
| Insulet Corporation | 4 | $95 |
| Vertex Pharmaceuticals Incorporated | 1 | $90 |
| Lilly USA, LLC | 5 | $82 |
Products named: REPATHA, TZIELD, Dexcom G6 Transmitter, Senza, FREESTYLE LIBRE, Ozempic, Tymlos, FREESTYLE LIBRE 3.
Industry payments across MO — which companies pay providers there.
